What is Import Alert 25-21?

Import Alert 25-21, “Detention without physical examination of enoki mushrooms from the Republic of Korea and China due to Listeria monocytogenes”, is an FDA import alert. Its listed firms are on the green list, which exempts their listed products from detention without physical examination under that alert; FDA last published the alert on July 6, 2026.

Which firms are on Import Alert 25-21?

As of October 25, 2026, 1 firm is listed on Import Alert 25-21 in 1 country; the most listings are in South Korea (1). The full table, grouped by country, is below on this page and every firm links to its record.

How do firms get off Import Alert 25-21?

A firm asks FDA to remove it by submitting evidence that the cause of the listing has been corrected. The Guidance section of the alert on FDA's website gives the procedure and the contact for 25-21; our guide explains the steps and the evidence FDA usually asks for.

What charge does FDA use under Import Alert 25-21?

The charge section of Import Alert 25-21 names LISTERIA (Listeria monocytogenes). Each code is a refusal charge in FDA's reference table; the linked pages give FDA's official statement and refusal counts.

Import Alert 25-21: Detention without physical examination of enoki mushrooms from the Republic of Korea and China due to Listeria monocytogenes

FDA last published July 6, 2026FDA alert page

As of October 25, 2026, FDA Import Alert 25-21 (Enoki mushrooms from Korea and China: Listeria) lists 1 firm on its green list in 1 country, covering enoki mushrooms; 0 firms were added and 0 removed in the last 90 days.

Data from FDA public records, last checked October 25, 2026. Request a correction

1
firms on the green list: 1
country: 0
added in the last 90 days: 0
removed in the last 90 days

What changed in the last 90 days

Additions use the date FDA published each listing. Removals are dated by the day SupplierRadar first saw the firm gone; the weekly and daily checks are described on the data sources page.

Removed from Import Alert 25-21

SupplierRadar has recorded no removals from Import Alert 25-21 in the last 90 days, as of October 25, 2026. A removal is shown at the top of this page, and on the firm's own page, the day it is found.

Added to Import Alert 25-21

No firm was added to Import Alert 25-21 in the last 90 days, as of October 25, 2026.

Firms on Import Alert 25-21, by country

1 listing in 1 country. Each name links to the firm's FDA record history; the date is the one FDA published on the alert.

Listings by country

Import alert listings by country
Country	Green list	Total
South Korea	1	1

South Korea (1)

FDA refusals from South Korea

Firms in South Korea on Import Alert 25-21
Firm	List	Products	Date published
H.A.Co.,Ltd.Cheongdo	Green	Enoki Mushroom	Apr 4, 2025

Refusal charges named on this alert

FDA's alert page names these charge codes. The counts are refusal lines FDA recorded under each charge since October 2016, for all firms, not only firms on this alert.

Charge codes named on Import Alert 25-21
Charge code	Meaning	Refusal lines since 2016
LISTERIA	Listeria monocytogenes	1,033

What the alert covers and why FDA issued it

FDA's wording, with FDA's change markers removed.

Official title: Detention Without Physical Examination of Enoki Mushrooms from the Republic of Korea and China due to Listeria Monocytogenes
Product scope: Enoki Mushrooms; Seafood Mushrooms; Enokitake; Seafood; Needle; Snow White Mushrooms; Futu; Lily
Last published: July 6, 2026

During fiscal years 2021-2023, FDA sampled and analyzed enoki mushrooms (also known as enokitake, seafood, golden needle, futu, or lily mushrooms) imported from a number of countries. At the time of the initial issuance of this alert, FDA analysis found that 43% of sampled enoki mushrooms from the Republic of Korea were contaminated with Listeria monocytogenes (L. monocytogenes), a human pathogen. At the time of the addition of the country of China to this alert, FDA analysis found that 15% of sampled enoki mushrooms from China were contaminated with L. monocytogenes.
An FDA investigation into a multistate outbreak spanning from 2016 through 2020 linked multiple cases of human infections with L. monocytogenes (listeriosis) to enoki mushrooms from the Republic of Korea. The outbreak accounted for a total of 36 U.S. clinical cases reported across 17 states, 12 cases in Canada, and six cases in Australia. The 36 U.S. cases yielded 31 hospitalizations and four deaths. In November 2022, an FDA investigation into a multistate outbreak accounting for three cases of human infections with listeriosis was linked to enoki mushrooms labeled as a product of China.

FDA Import Alert 25-21, Reason for AlertRead it on FDA

Read the rest of the reason

From October 2020 through January 2023, state public health authorities conducted sampling of enoki mushrooms from retail locations. L. monocytogenes was detected in multiple state samples, which led to 18 recalls of enoki mushrooms in the U.S. since 2021. Eight of the recalls were linked to enoki mushrooms grown in the Republic of Korea, and 10 from China, confirmed via labeling, traceback, or whole genome sequencing (WGS). During this timeframe FDA sampled and analyzed 91 shipments of enoki mushrooms imported from the Republic of Korea for L. monocytogenes and found 24 to be violative. This represents a violation rate of 26%. Additionally, FDA sampled and analyzed 111 shipments of enoki mushrooms imported from China and found 16 to be violative. Additional sampling performed as part of the November 2022 outbreak response resulted in a 15% violation rate. This effort identified a total of 12 firms with violative product out of 29 declared to have exported enoki mushrooms from the Republic of Korea to the U.S., and 12 firms with violative product out of 26 declared to have exported enoki mushrooms from China to the U.S.

Based on the outbreak and high sampling violation rate for the Republic of Korea and China, FDA believes that it is extremely unlikely that contamination of enoki mushrooms with L. monocytogenes is due to an isolated incident. Further, FDA's findings of L. monocytogenes strains with the same WGS in multiple shipments over a period of time suggest that there may be resident pathogens in mushroom operations in the Republic of Korea and China. Evidence suggests that enoki mushrooms may be a high-risk reservoir for L. monocytogenes due to difficulty maintaining good hygienic practices at medium-sized plants where the mushrooms are typically produced.

Accordingly, enoki mushrooms imported from the Republic of Korea and China appear to be adulterated under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), because they appear to contain Listeria monocytogenes, an added poisonous or deleterious substance that may render food injurious to health within the meaning of section 402(a)(1) of the FD&C Act.

Listing on an import alert is FDA's notice to the firm and a fact an importer must consider in its supplier evaluation under 21 CFR 1.505. What the red, green and yellow lists mean.

Questions about Import Alert 25-21

What is Import Alert 25-21?: Import Alert 25-21, “Detention without physical examination of enoki mushrooms from the Republic of Korea and China due to Listeria monocytogenes”, is an FDA import alert. Its listed firms are on the green list, which exempts their listed products from detention without physical examination under that alert; FDA last published the alert on July 6, 2026.
Which firms are on Import Alert 25-21?: As of October 25, 2026, 1 firm is listed on Import Alert 25-21 in 1 country; the most listings are in South Korea (1). The full table, grouped by country, is below on this page and every firm links to its record.
How do firms get off Import Alert 25-21?: A firm asks FDA to remove it by submitting evidence that the cause of the listing has been corrected. The Guidance section of the alert on FDA's website gives the procedure and the contact for 25-21; our guide explains the steps and the evidence FDA usually asks for.
What charge does FDA use under Import Alert 25-21?: The charge section of Import Alert 25-21 names LISTERIA (Listeria monocytogenes). Each code is a refusal charge in FDA's reference table; the linked pages give FDA's official statement and refusal counts.
Which firms were added to Import Alert 25-21 recently?: No firm was added to Import Alert 25-21 in the last 90 days, as of October 25, 2026.
Which firms were removed from Import Alert 25-21 recently?: SupplierRadar has recorded no removals from Import Alert 25-21 in the last 90 days, as of October 25, 2026. A removal is shown at the top of this page and on the firm's page the day it is found.

Built for the person who signs the FSVP file

Look before you order.

Check up to five suppliers against every FDA record in one paste, no account needed. Watch the ones you buy from and get the source the day a record changes.

Check five suppliers free Watch a supplier free

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.